Contact
Translational Pathology & Spatial Biology CRO

From Tissue to Insight

High-resolution spatial pathology fluorescence tissue image

Pathora Bio is building an execution-focused translational pathology CRO for histology, multiplex IHC/IF, digital pathology, biomarker analytics, spatial-ready tissue workflows, and clinical trial support.

Histology
Multiplex IHC/IF
Digital Pathology
Biomarker Analytics
Clinical Trial Support
ISH Assays
Spatial-Ready QC
The Business Case

A pathology infrastructure business built around execution.

Pathora Bio translates advanced tissue science into a clear business problem: fragmented academic and vendor workflows delay tissue biomarker programs for pharma, biotech, and clinical research teams.

Operational pain one roof workflow

Operational Pain

Clients lose time when tissue retrieval, pathology review, sectioning, staining, imaging, and analysis are split across disconnected groups.

Premium Service Model real representative photo

Premium Service Model

Positioned as a high-end translational pathology CRO, not a commodity histology lab.

Miami-Based, Global Reach real representative photo

Miami-Based, Global Reach

Headquartered in Miami with a scalable model for national and international pharma, biotech, and translational research clients.

Investor-Friendly Story real representative photo

Investor-Friendly Story

The value is simple: faster execution, better tissue biomarker data, accountable delivery, and CRO-grade quality systems.

Core Services

Integrated tissue biomarker services

Flexible specimen intake and end-to-end project ownership for pharma, biotech, and translational oncology teams.

Histology & H&E

FFPE sectioning, H&E, unstained slides, TMAs, and research-ready tissue preparation.

IHC / IF Assay Development

Targeted biomarker staining, assay optimization, controls, and reproducibility-focused workflows.

ISH Assays

RNA/DNA in situ hybridization assay support, including FISH/RNAscope-style workflows and tissue-based molecular localization.

Multiplex Imaging

Multiplex IF/IHC and spatial-ready tissue imaging for translational biomarker programs.

Digital Pathology Analytics

Quantitative pathology, segmentation, biomarker scoring, spatial analysis, and report-ready outputs.

Workflow

End-to-end tissue-to-data execution

One accountable workflow across intake, pathology review, histology, staining, imaging, analysis, and delivery.

1

Specimen Intake

Blocks, slides, TMAs, sections, stained slides, WSIs, and de-identified data.

2

Pathology Review

ROI selection, tissue suitability, necrosis, tumor content, and assay feasibility.

3

Histology & Assay QC

Sectioning, H&E, staining controls, panel verification, and tissue-readiness gates.

4

Imaging & Analysis

Whole-slide imaging, multiplex imaging, digital pathology, and biomarker analytics.

5

Report Delivery

Structured deliverables, image files, quantified data, QC notes, and scientific interpretation.

Innovation

Interactive scientific workflow

Explore the Pathora Bio interactive workflow platform. On phones, a mobile workflow card appears first; desktop and tablet users see the full widescreen interactive slide workflow.

Pathora Bio innovation workflow

Integrated Translational Pathology Platform

Visualizes scientific consultation, assay strategy, sample processing, analysis, and secure delivery.

Launch Interactive Workflow
Standards & Compliance

Quality systems built into the operating model.

Pathora Bio is designed around reproducibility, traceability, QA/QC, regulatory readiness, specimen tracking, SOPs, and CRO-grade documentation.

CLIA

CLIA Readiness Framework

Clinical laboratory operational standards, QC oversight, specimen traceability, and scalable compliance workflows.

CAP

CAP-Aligned Quality Systems

SOP-driven design supporting reproducibility, audit readiness, workflow standardization, and CRO-grade execution.

QA

Quality & Compliance Infrastructure

Accountability, specimen tracking, reporting consistency, operational transparency, and high-end translational pathology workflows.

CLIACLIA Roadmap
CAPCAP Readiness
ISOISO-Aligned Process
GLPGLP Principles
Investment Opportunity

Investor Opportunities

Pathora Bio is positioned at the intersection of translational pathology, multiplex tissue imaging, digital pathology, biomarker analytics, and clinical trial support.

$8B+CRO histopathology & biomarker market
22%Multiplex IF & spatial biology CAGR
$2.5MSeed buildout target
GlobalPharma & biotech reach
Thomas Lisse, PhD

Founder & Chief Scientific Officer

Thomas Lisse, PhD

NIH-trained translational scientist and director-level translational pathology operator with expertise in histology, multiplex tissue imaging, digital pathology, biomarker analytics, spatial biology, and clinical trial support workflows.

Built from direct experience managing real-world academic cancer center bottlenecks and supporting CAP/CLIA-aligned CRO spatial imaging and genomics operations in industry.

Request Investor Deck
Contact

Ready to advance your translational research?

Submit your inquiry and a member of the scientific team will respond promptly.

Email: info@pathorabio.com
Phone: 786-519-3564
LinkedIn: Pathora Bio